What This Therapeutics Insider Signals Revenue Momentum
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Explore the best credit cards that provide cash back without any fees. Start saving more on your purchases!
26,647 articlesA high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Broadcom’s latest price move came on the back of a price-target cut and AI optimism colliding with caution. This guid...
Strategy unveiled a plan to repurchase roughly $1.5 billion of its 2029 notes, with funding options including Bitcoin...
As July 29 approaches, investors eye Microsoft’s Q4 results for a potential breakout. This article lays out why the s...
On Holding's stock has caught the eye of many long-term investors who pay attention to fundamentals rather than short...
A broad market ETF like SCHX hides a sharp concentration at the top. The three largest positions drive about 48% of t...
Microsoft is riding a fast-growing AI wave, but its stock hasn’t followed the surge. Here’s how analysts and models v...
Adobe sits as a candidate undervalued stock that could rebound in 2026, trading in the low-$280s with a 16x trailing ...
Meta is betting big on subscriptions with Meta One to pair recurring revenue with AI capability. The thing investors ...
A hypothetical $10,000 Exxon investment at the outbreak of the Iran conflict has produced a mixed bag of results. Her...
As KVHI gears up for the 2025 earnings call, investors should focus on revenue drivers, margins, and long-term strate...
Salesforce stock has faced renewed pressure as growth slows and concerns about AI monetization persist. This pragmati...